Etiology and overview of heart failure

Advances in Heart Failure Management

Volumn , Issue , 2012, Pages 7-17

  Wong, Yee Weng ^a   Felker, G Michael ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906914358     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.11.229     Document Type: Chapter

References (22)

1. Levy D, Kenchaiah S, Larson MG et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347(18), 1397-1402 (2002).
2. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292(3), 344-350 (2004).
3. Hunt SA, Abraham WT, Chin MH et al. Focused update incorporated into the ACC/ AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119(14), e391-e479 (2009).
4. Redfield MM, Jacobsen SJ, Burnett JC et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289(2), 194-202 (2003).
5. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics -2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 119(3), e21-e181 (2009).
6. Cowie MR, Wood DA, Coats AJ et al. Incidence and aetiology of heart failure; a population-based study. Eur. Heart J. 20(6), 421-428 (1999).
7. Bleumink GS, Knetsch AM, Sturkenboom MC et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam study. Eur. Heart J. 25(18), 1614-1619 (2004).
8. Lloyd-Jones DM, Larson MG, Leip EP et al. Lifetime risk for developing congestive heart failure: the Framingham heart study. Circulation 106(24), 3068-3072 (2002).
9. Wang TJ, Evans JC, Benjamin EJ et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108(8), 977-982 (2003).
10. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog. Cardiovasc. Dis. 47(5), 320-332 (2005).
11. Owan TE, Hodge DO, Herges RM et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355(3), 251-259 (2006).
12. Fonarow GC, Stough WG, Abraham WT et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J. Am. Coll. Cardiol. 50(8), 768-777 (2007).
13. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 27(22), 2725-2736 (2006).
14. Stewart S, MacIntyre K, Hole DJ et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur. J. Heart Fail. 3(3), 315-322 (2001).
15. Murdoch DR, Love MP, Robb SD et al. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur. Heart J. 19(12), 1829-1835 (1998).
16. Teng TH, Hung J, Knuiman M et al. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005. Int. J. Cardiol. doi.org/10.1016/j. ijcard.2011.01.061 (2011) (Epub ahead of print).
17. Henkel DM, Redfield MM, Weston SA et al. Death in heart failure: a community perspective. Circulation Heart Fail. 1(2), 91-97 (2008).
18. Gheorghiade M, Sopko G, De Luca L et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 114(11), 1202-1213 (2006).
19. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J. Am. Coll. Cardiol. 39(2), 210-218 (2002).
20. Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA 275(20), 1557-1562 (1996).
21. Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342(15), 1077-1084 (2000).
22. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels (9th Edition). Little Brown & Co, NY, USA, 253-256 (1994).